Ardent Health drops on $116 mln secondary offering

By Reuters News

** Shares of hospital operator Ardent Health ARDT.N drop 15.1% to $15.07 premarket on Weds after $116 mln secondary offering pricing

** ARDT late Tues announced 8 mln shares, comprising sale of ~7.1 mln shares by affiliate of Equity Group Investments (EGI) and 863,281 shares by affiliate of Ventas VTR.N, at $14.50

** Offering price is 18.3% discount to stock's last close

** ARDT will concurrently repurchase 1.5 mln shares from the underwriters as part of offering

** JP Morgan and Barclays leading offering, along with seven other bookrunners

** Prior to offering, EGI-AM Investments owned 54.8% stake and Ventas held 6.6% stake in ARDT, according to the prospectus

** Brentwood, Tennessee-based ARDT has ~140.9 mln shares outstanding

** Through Tues, stock has doubled YTD including 47.5% surge in Nov

** Health insurers and hospital stocks rallied earlier this month after sweeping midterm election win by Democrats fueled hopes of sector-friendly policy changes

** Avg rating of 12 analysts covering ARDT is "buy"; median PT of $18 up from $13 a month ago, per LSEG data

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk